Live Breaking News & Updates on Biocon group

Stay informed with the latest breaking news from Biocon group on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biocon group and stay connected to the pulse of your community

Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss - Eli Lilly and Co (NYSE:LLY), Bristol-Myers Squibb (NYSE:BMY)

Eli Lilly's CEO, David Ricks, outlines plans to launch the obesity drug Tirzepatide in India next year, presenting opportunities amid competition from Novo Nordisk. Bristol Myers Squibb expands its R&D footprint, eyeing India as a pivotal hub for innovation and clinical trials.

India , United-states , Denmark , Hyderabad , Andhra-pradesh , Danish , Eli-lilly , Bristol-myers-squibb , David-ricks , Bristol-myers-squibb-co , Novo-nordisk , Christopher-boerner

Bristol Myers CEO says India to have largest R&D presence outside US by 2025

Bristol Myers Squibb
aims to expand its research and development presence in
India and expects its newly inaugurated Hyderabad facility to
become its largest unit outside the U.S. by 2025,...

India , Bengaluru , Karnataka , Hyderabad , Andhra-pradesh , Janane-venkatraman , Christopher-boerner , Leroy-leo , Bristol-myers , Rishika-sadam , Biocon-group-syngene-international , Reuters

Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025

The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence, he said in his keynote speech at the BioAsia conference.

Bengaluru , Karnataka , India , Hyderabad , Andhra-pradesh , Christopher-boerner , Bristol-myers , Biocon-group-syngene-international , Bristol-myers-squibb , Reuters , Biocon-group , Biocon

Bristol Myers CEO says India to have largest R&D presence outside US by 2025 | Company News

Bristol Myers CEO says India to have largest R&D presence outside US by 2025 | Company News
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

India , Bengaluru , Karnataka , Hyderabad , Andhra-pradesh , Bristol-myers , Biocon-group-syngene-international , Biocon-group , Last-updated ,

Biocon included in S&P Global Sustainability Yearbook 2024

Biocon included in S&P Global Sustainability Yearbook 2024
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India , Kiran-mazumdar-shaw , Biocon-biologics , Biocon-group , Biocon , Biocon-limited-on , Biocon-limited , Sustainability-yearbook , Biocon-biologics-limited , Patient-equity , People-equity , Environmental-equity

Biocon CFO Indranil Sen resigns

Sen was appointed as the CFO of the company in April 2021 after Anupam Jindal stepped down. He has over 20 years of experience in financial planning, treasury, taxation and financial reporting.

Anupam-jindal , Indranil-sen , Biocon-group , Key-managerial-personnel-of-the-company , Chief-financial-officer , Key-managerial-personnel , Cfo , Company , Pharma , Financial-planning , Treasury , Biocon-cfo

ColorTokens launches microsegmentation capabilities with Xshield

These advancements reinforce the company's commitment to providing IT and security leaders with breach-ready confidence by stopping the lateral spread of malware.

Abdulla-kagalwalla , Rajesh-khazanchi , Agnidipta-sarkar , Operational-technology , Colortokens-inc , Biocon-group , Zero-trust , State-of-iot-security , Vice-president , Xshield-enterprise-microsegmentation ,

India News | OCTF's Guidelines for Head & Neck Cancer Recognized Among 13 Worldwide Clinical Practice Advice

Get latest articles and stories on India at LatestLY. The OCTF's consensus guidelines were included in the journal Cancers as part of a scoping review that identified and compared the worldwide clinical practice guidelines for treating oral, oropharynx, and larynx cancer. India News | OCTF's Guidelines for Head & Neck Cancer Recognized Among 13 Worldwide Clinical Practice Advice.

India , Mumbai , Maharashtra , Anupama-shetty , Kiran-mazumdar-shaw , Oral-cancer-task-force , Biocon-group , Biocon-foundation , Consensus-guidelines , Neck-cancer , Govt-officer-dies , Jumps-off-fourth-floor

OCTF's guidelines for Head & Neck Cancer recognized among 13 worldwide clinical practice advice

OCTF's guidelines for Head & Neck Cancer recognized among 13 worldwide clinical practice advice
webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.

India , Kiran-mazumdar-shaw , Anupama-shetty , Biocon-group , Oral-cancer-task-force , Biocon-foundation , Consensus-guidelines , Neck-cancer , Indian-journal , Managing-trustee , Mission-director , Cancer-journal

Oral cancer task force's guidelines for Head & Neck cancer recognised among 13 worldwide clinical practice guidelines - News Healthcare

Oral cancer task force's guidelines for Head & Neck cancer recognised among 13 worldwide clinical practice guidelines - News Healthcare
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India , Japan , Canada , Kiran-mazumdar-shaw , Anupama-shetty , National-comprehensive-cancer-network , Journal-of-cancer-research-statistics , Oral-cancer-task-force , Biocon-group , Biocon-foundation , Consensus-guidelines , Neck-cancer